Evidence map›Paper›PMID 42225709›Full record

Trial reportScientific reports2026

Holter-ECG findings after acute ischemic stroke and TIA: A systematic analysis of the MonDAFIS randomized trial.

Niklas Thießen, Manuel C Olma, Serdar Tütüncü, Muhammad Jawad-Ul-Qamar, Claudia Kunze, Götz Thomalla, Darius G Nabavi, Joachim Röther, Ulrich Laufs, Roland Veltkamp and 5 more

Abstract readRandomized Controlled TrialMulticenter Study
In one paragraph

Trial report in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Niklas Thießen *Department of Cardiology, University Heart and Vascular Center Hamburg, University Medical Center Hamburg- Eppendorf (UKE), Hamburg, Germany.
Manuel C Olma *Center for Stroke Research Berlin, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Serdar TütüncüCenter for Stroke Research Berlin, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Muhammad Jawad-Ul-QamarDepartment of Cardiology, Castle Hill Hospital, Hull University Teaching Hospitals, NHS trust, Hull, UK.
Claudia KunzeCenter for Stroke Research Berlin, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Götz ThomallaDepartment of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Darius G NabaviDepartment of Neurology, Vivantes Klinikum Neukölln, Berlin, Germany.
Joachim RötherDepartment of Neurology, Asklepios Klinik Altona, Hamburg, Germany.
Ulrich LaufsKlinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig, Leipzig, Germany.
Roland VeltkampDepartment of Neurology, Alfried Krupp Krankenhaus, Essen, Germany.
Peter U HeuschmannInstitute for Clinical Epidemiology and Biometry, University of Würzburg, Würzburg, Germany.
Paulus KirchhofDepartment of Cardiology, University Heart and Vascular Center Hamburg, University Medical Center Hamburg- Eppendorf (UKE), Hamburg, Germany.
Matthias EndresCenter for Stroke Research Berlin, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Karl Georg HaeuslerDepartment of Neurology, Universitätsklinikum Ulm, Ulm, Germany.
Renate B SchnabelDepartment of Cardiology, University Heart and Vascular Center Hamburg, University Medical Center Hamburg- Eppendorf (UKE), Hamburg, Germany. r.schnabel@uke.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Holter-ECG monitoring is a critical component of post-stroke diagnostics, guiding cardiac work-up and secondary stroke prevention. Abnormal ECG findings beyond atrial fibrillation (AF) in stroke patients remain understudied. The prospective multicenter MonDAFIS trial randomized patients with acute ischemic stroke or transient ischemic attack (TIA) without known AF to Holter-ECG recording up to 7 days or usual care. Holter-ECG findings from the first 72 h of the intervention arm were analyzed to provide a reference guide in clinical practice. Furthermore, 24-hour and 72-hour Holter-ECG monitoring were compared to analyze the value of prolonged monitoring. 24-hour Holter-ECGs from 1,665 patients (median age 67; 40.4% women) identified supraventricular tachycardia (SVT) in 4.1% and newly-diagnosed AF in 2.2% of patients. Premature ventricular complexes were common (85.8%), ventricular couplets (28.0%) or bigeminy (14.0%) less common. Non-sustained ventricular tachycardia (nsVT) was detected in 1.7% of patients. Extended 72-hour-monitoring in 1,283 patients led to higher detection rates across all abnormalities, doubling nsVT (4.4%) and SVT (8.8%) detection rates. Generally, we observed higher detection rates with older age. Detection rates of supraventricular arrhythmias were higher in women, whereas men exhibited higher rates of ventricular abnormalities. Post-stroke ECG monitoring detects various arrhythmias beyond AF in a substantial proportion of individuals. Longer monitoring and older age are associated with increased detection rates, with notable sex-specific differences.

Indexed as

Electrocardiography, AmbulatoryIschemic Attack, TransientIschemic StrokeAgedAtrial FibrillationFemaleHumansMaleMiddle AgedProspective StudiesStrokeAtrial fibrillationECG monitoringStroke

Identifiers

PMID42225709
PMCPMC13226722

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.